Induced pluripotent stem cells: current progress and potential for regenerative medicine

Trends in Molecular Medicine

Volumn 15, Issue 2, 2009, Pages 59-68

  Amabile, Giovanni ^a,b   Meissner, Alexander ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN LIN 28; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

CELL CYCLE; CELL DIFFERENTIATION; CELL FUSION; CELL MATURATION; CELL NUCLEUS TRANSPLANTATION; CHROMATIN STRUCTURE; DNA METHYLATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HUMAN; KARYOTYPE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENOME; HUMANS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

IPS;

EID: 60649084367     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.12.003     Document Type: Review

References (79)

1. Jaenisch R., and Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132 (2008) 567-582
2. Hochedlinger K., and Jaenisch R. Nuclear reprogramming and pluripotency. Nature 441 (2006) 1061-1067
3. Tada M., et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11 (2001) 1553-1558
4. Cowan C.A., et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
5. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
6. Wernig M., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
7. Maherali N., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
8. Kanatsu-Shinohara M., et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119 (2004) 1001-1012
9. Briggs R., and King T.J. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl. Acad. Sci. U. S. A. 38 (1952) 455-463
10. Gurdon J. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10 (1962) 622-640
11. Meissner A., and Jaenisch R. Mammalian nuclear transfer. Dev. Dyn. 235 (2006) 2460-2469
12. Campbell K.H., et al. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380 (1996) 64-66
13. Thomson J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
14. Hochedlinger K., and Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 349 (2003) 275-286
15. Rideout III W.M., et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109 (2002) 17-27
16. Egli D., et al. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 447 (2007) 679-685
17. Okita K., et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 (2008) 949-953
18. Stadtfeld M., et al. Induced pluripotent stem cells generated without viral integration. Science 322 (2008) 945-949
19. Hanna J., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
20. Wernig M., et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5856-5861
21. Dimos J.T., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008) 1218-1221
22. Park I.H., et al. Disease-specific induced pluripotent stem cells. Cell 134 (2008) 877-886
23. Rubin L.L. Stem cells and drug discovery: the beginning of a new era?. Cell 132 (2008) 549-552
24. Osafune K., et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26 (2008) 313-315
25. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
26. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
27. Aasen T., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26 (2008) 1276-1284
28. Aoi T., et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321 (2008) 699-702
29. Stadtfeld M., et al. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2 (2008) 230-240
30. Mikkelsen T.S., et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454 (2008) 49-55
31. Avilion A.A., et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17 (2003) 126-140
32. Rowland B.D., and Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 6 (2006) 11-23
33. Brambrink T., et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2 (2008) 151-159
34. Hanna J., et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133 (2008) 250-264
35. Wernig M., et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26 (2008) 916-924
36. Maherali N., et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3 (2008) 340-345
37. Hockemeyer D., et al. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3 (2008) 346-353
38. Lowry W.E., et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2883-2888
39. Niwa H., et al. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 (2000) 372-376
40. Bernstein B.E., et al. The mammalian epigenome. Cell 128 (2007) 669-681
41. Bernstein B.E., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
42. Mikkelsen T.S., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
43. Meissner A., et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454 (2008) 766-770
44. Meissner A., et al. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25 (2007) 1177-1181
45. Rougier N., et al. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 12 (1998) 2108-2113
46. Imamura M., et al. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev. Biol. 6 (2006) 34
47. Jones P.A., et al. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6117-6121
48. Humpherys D., et al. Epigenetic instability in ES cells and cloned mice. Science 293 (2001) 95-97
49. Rugg-Gunn P.J., et al. Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum. Mol. Genet. 16 (2007) R243-R251
50. Holm T.M., et al. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8 (2005) 275-285
51. Eggan K., et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6209-6214
52. Schöler H.R., et al. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8 (1989) 2543-2550
53. Nichols J., et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
54. Yuan H., et al. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9 (1995) 2635-2645
55. Boyer L.A., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 (2005) 947-956
56. Masui S., et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9 (2007) 625-635
57. Nakagawa M., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26 (2008) 101-106
58. Schmidt E.V. The role of c-myc in cellular growth control. Oncogene 18 (1999) 2988-2996
59. Murphy M.J., et al. More than just proliferation: Myc function in stem cells. Trends Cell Biol. 15 (2005) 128-137
60. Wernig M., et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2 (2008) 10-12
61. Huangfu D., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26 (2008) 1269-1275
62. Eminli S., et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous sox2 expression. Stem Cells 26 (2008) 2467-2474
63. Kim J.B., et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454 (2008) 646-650
64. Segre J.A., et al. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22 (1999) 356-360
65. Zhao W., et al. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23 (2004) 395-402
66. Li Y., et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105 (2005) 635-637
67. Chambers I., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
68. Mitsui K., et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 (2003) 631-642
69. Chambers I., et al. Nanog safeguards pluripotency and mediates germline development. Nature 450 (2007) 1230-1234
70. Moss E.G., et al. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88 (1997) 637-646
71. Polesskaya A., et al. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 21 (2007) 1125-1138
72. Viswanathan S.R., et al. Selective blockade of microRNA processing by Lin28. Science 320 (2008) 97-100
73. Huangfu D., et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26 (2008) 795-797
74. Hochedlinger K., and Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415 (2002) 1035-1038
75. Serwold T., et al. Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes. J. Immunol. 179 (2007) 928-938
76. Koralov S.B., et al. Direct in vivo VH to JH rearrangement violating the 12/23 rule. J. Exp. Med. 201 (2005) 341-348
77. Zhou Q., et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455 (2008) 627-632
78. Stadtfeld M., et al. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol. 18 (2008) 890-894
79. Shi Y., et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3 (2008) 568-574